Atrial Fibrillation Network: Clinical Trials

18 trials sponsored by Atrial Fibrillation Network, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 8 Not applicable, 3 Phase 3, 3 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 33Completed 2, Terminated 1
Phase 43Completed 3
Phase 21Terminated 1

Follow Atrial Fibrillation Network: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair
Usual Care, Pulmonary Vein Isolation - Atrial Fibrillation (AF), Mitral Valve (MV) Regurgitation
Not applicableNot yet recruitingAtrial Fibrillation Network9562026-09-012026-09-10
PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study
Ablation of atrial fibrillation (AF) - Atrial Fibrillation
Not applicableRecruitingAsklepios proresearch2642026-08-192026-10-06
Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)
Early atrial fibrillation ablation, Usual Care - Atrial Fibrillation
Not applicableRecruitingAtrial Fibrillation Network23122024-10-142026-01-08
Clinical Cohorts for Validation of New Digital Biomarkers
Atrial Fibrillation, Atrial Cardiomyopathy
CompletedAtrial Fibrillation Network5152023-03-022026-10-21
From the Emergency Department Directly to Ablation of Atrial Fibrillation Study
Ablation of atrial fibrillation (AF) - Atrial Fibrillation (AF)
Not applicableActive not recruitingAsklepios proresearch3502021-12-152026-10-20
The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9)
Preventicus heartbeat app in combination with wearables - Atrial Arrhythmia
Not applicableCompletedAtrial Fibrillation Network8822021-01-262022-07-07
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
CE-mark approved LAA closure devices, Acetylsalicylic acid, Clopidogrel - Atrial Fibrillation
Phase 4CompletedCharite University, Berlin, Germany9122018-02-282025-12-12
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
Apixaban, Phenprocoumon - Atrial Fibrillation, End-stage Kidney Disease
Phase 3CompletedAtrial Fibrillation Network1082017-06-202022-09-27
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Edoxaban, ASA - Atrial High Rate Episodes
Phase 3TerminatedAtrial Fibrillation Network26082016-02-012025-02-06
Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Vitamin K antagonist, Apixaban - Atrial Fibrillation
Phase 4CompletedAtrial Fibrillation Network6762014-12-012017-10-20
Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
Dabigatran etexilate, Phenprocoumon - Atrial Fibrillation or Atrial Flutter, Thrombosis of Left Atrial Appendage
Phase 2TerminatedJohannes Gutenberg University Mainz642014-07-012019-07-26
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial
early standardised rhythm control - Atrial Fibrillation, Stroke
Phase 4CompletedAtrial Fibrillation Network27892011-07-012020-07-23
KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation
external electrical cardioversion - Atrial Fibrillation
Not applicableWithdrawnAtrial Fibrillation Network2006-09-012012-09-03
Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrillation
Pulmonary vein ablation - Atrial Fibrillation
Not applicableCompletedAtrial Fibrillation Network2322006-02-012012-09-10
Flecainide-Short Long Study (Flec-SL)
Flecainide - Atrial Fibrillation
Not applicableCompletedAtrial Fibrillation Network7602005-03-012012-09-11
Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
Olmesartan - Heart Disease, Arrhythmia
Phase 3CompletedAtrial Fibrillation Network4222005-01-012012-09-11
Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug Therapy
Atrial Fibrillation
CompletedAtrial Fibrillation Network2632005-01-012012-09-10
Prospective Registration and Assessment of Serious Adverse Events Within the AFNET
Atrial Fibrillation, Assessment of Serious Advers Events
CompletedAtrial Fibrillation Network130002004-02-012020-09-22

Conditions studied

Atrial Fibrillation (17)  ·  Stroke (3)  ·  Arrhythmias, Cardiac (1)  ·  Atrial Flutter (1)  ·  Gastroesophageal Reflux (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Mitral Valve Insufficiency (1)  ·  Syncope (1)

Interventions

Phenprocoumon (4)  ·  apixaban (3)  ·  Dabigatran (2)  ·  Warfarin (2)  ·  edoxaban (2)  ·  Aspirin (1)  ·  Clopidogrel (1)  ·  Flecainide (1)  ·  Rivaroxaban (1)  ·  acarboxyprothrombin (1)  ·  fluindione (1)  ·  olmesartan (1)

Countries

Germany (16)  ·  Spain (5)  ·  Netherlands (4)  ·  Poland (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Denmark (3)  ·  Italy (3)  ·  Austria (2)  ·  Czechia (2)  ·  France (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Greece (1)

Top investigators

Stephan Willems, MD (3)  ·  Paulus Kirchhof, Prof. Dr. (2)  ·  Andreas Goette, MD (1)  ·  Andreas Rillig, PD Dr. (1)  ·  Andreas Schuchert, Prof. Dr. (1)  ·  Antonia Zapf, Prof. Dr. (1)  ·  Arian Sultan, MD (1)  ·  Daniel Steven, MD (1)  ·  G Breithardt, Prof (1)  ·  Holger Reinecke, Prof. Dr. (1)  ·  Jason Andrade, Prof. Dr. (1)  ·  Karl-Heinz Kuck, MD (1)  ·  Kevin Vernooy, Prof. Dr. (1)

Results publications

PMID 34447995, PMID 41766700, PMID 12860855, PMID 20958836, PMID 22157519, PMID 22713626, PMID 23577826, PMID 23871349, PMID 24016492, PMID 24016511, PMID 24134539, PMID 24351885, PMID 24665920, PMID 25643988, PMID 26763226, PMID 27042964, PMID 27516462, PMID 27567408, PMID 27742775, PMID 28201538, PMID 28506916, PMID 28751544, PMID 28964382, PMID 29300976, PMID 30206088, PMID 30342299, PMID 30821012, PMID 30874766, PMID 31431051, PMID 31510841, PMID 32107811, PMID 32632547, PMID 32725107, PMID 32865375, PMID 33197158, PMID 33197159, PMID 34328366, PMID 34978360, PMID 35135308, PMID 35387433, PMID 35550691, PMID 35863844, PMID 35968706, PMID 36036648, PMID 36335915, PMID 36517170, PMID 36710894, PMID 36813380, PMID 37264683, PMID 37622677

NIH funding

2014 (1), 2015 (1)